Regulation of endothelial Nitric Oxide Synthase activity and gene expression

Annals of the New York Academy of Sciences

Volumn 962, Issue , 2002, Pages 122-130

  Wu, Kenneth K ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

ENOS; Gene therapy; Nitric oxide; Vascular biology

Indexed keywords

CALCIUM; CALMODULIN; HEAT SHOCK PROTEIN 90; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; NITRIC OXIDE SYNTHASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN KINASE B; SERINE; TRANSCRIPTION FACTOR SP1;

CALCIUM CELL LEVEL; CARBOXY TERMINAL SEQUENCE; CONFERENCE PAPER; ENDOTHELIUM CELL; ENHANCER REGION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME REGULATION; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; HUMAN; NONHUMAN; PROMOTER REGION; TRANSCRIPTION REGULATION;

ANIMALIA; JANUS; TRIXIS;

EID: 0036276672     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2002.tb04062.x     Document Type: Conference Paper

References (58)

1. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine
2. Vascular endothelial cells synthesize nitric oxide from L-arginine
3. Endothelium-derived relaxing factor produced and released from artery and vein in nitric oxide
4. Nitric oxide synthase: Aspects concerning structure and catalysis
5. Nitric oxide synthases: Roles, tolls, and controls
6. Inducible cyclooxygenase and nitric oxide synthase
7. Nitric oxide synthases: Structure function and inhibition
8. Structure and chromosomal localization of the human constitutive endothelial NO synthase
9. Endothelial nitric oxide synthase: Molecular cloning and characterization of a distinct constitutive enzyme isoform
10. Molecular cloning and expression of a cDNA encoding endothelial cell nitric oxide synthase
11. Elevated blood pressure in mice lacking endothelial nitric oxide synthase
12. Accelerated atherosclerosis, aortic aneurysm formation and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double knockout mice
13. Biosynthesis and palmitoylation of endothelial nitric oxide synthase: Mutagenesis of palmitoylation sites, cysteines-15 and/or -26, argues against depalmitoylation-induced translocation of the enzyme
14. The first 35 amino acids and fatty acylation sites determine the molecular targeting of endothelial nitric oxide synthase into the Golgi region of cells: A green fluorescent protein study
15. Acylation targets endothelial nitric-oxide synthase to plasmalemmal caveolæ
16. Targeting of nitric oxide synthase to endothelial cell caveolæ via palmitoylation: Implications for nitric oxide signaling
17. Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells
18. Direct interaction of endothelial nitric-oxide synthase and caveolin-1 inhibits synthase activity
19. Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the NOS caveolin binding domain in vivo
20. An autoinhibitory control element defines calcium-regulated isoforms of nitric oxide synthase
21. Autoinhibition of endothelial nitric-oxide synthase. Identification of an electron transfer control element
22. 2+/calmodulin-dependent electron transfer
23. Characterization of the roles of the 594-645 region in human endothelial nitric oxide synthase in regulating calmodulin binding and electron transfer
24. Evidence for a bidomain structure of constitutive cerebellar nitric oxide synthase
25. Endothelial nitric-oxide synthase. Evidence for bidomain structure and successful reconstitution of catalytic activity from two separate domains generated by a baculovirus expression system
26. Cysteine 184 of endothelial nitric oxide synthase is involved in heme coordination and catalytic activity
27. Mutation of Glu-361 in human endothelial nitric-oxide synthase selectively abolishes L-arginine binding without perturbing the behavior of heme and other redox centers
28. Crystal structure of constitutive endothelial nitric oxide synthase: A paradigm for pterin function involving a novel metal center
29. The structure of nitric oxide synthase oxygenase domain and inhibitor complexes
30. Structure of nitric oxide synthase oxygenase dimer with pterin and substrate
31. Structural characterization of nitric oxide synthase isoforms reveals striking active-site conservation
32. Crystal structures of zinc-free and -bound heme domain of human inducible nitric-oxide synthase. Implications for dimer stability and comparison with endothelial nitric-oxide synthase
33. Effects of Asp-369 and Arg-372 mutations on heme environment and function in human endothelial nitric oxide synthase
34. Cysteine 99 of endothelial nitric oxide synthase (NOS-III) is critical for tetrahydrobiopterin-dependent NOS-III stability and activity
35. Calmodulin controls neuronal nitric oxide synthase by a dual mechanism: Activation of intra- and inter-domain electron transfer
36. 2+-calmodulin and caveolin
37. Dynamic activation of endothelial nitric oxide synthase by Hsp90
38. Reconstitution of an endothelial nitric oxide synthase, hsp90 and caveolin-1 complex in vitro
39. Phosphorylation of endothelial nitric oxide synthase in response to fluid shear stress
40. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation
41. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt
42. Enhanced electron flux and reduced calmodulin dissociation may explain "calcium-independent" eNOS activation by phosphorylation
43. Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells: Elevations in tetrahydrobiopterin levels enhance endothelial nitric oxide synthase specific activity
44. What we know and we don't know about L-arginine and NO
45. Substrate supply for nitric oxide synthase in macrophages and endothelial cells: Role of cationic amino acid transporters
46. Regulation of endothelial nitric oxide synthase during hypoxia
47. 2+SOD are selectively upregulated by steady laminar shear stress
48. Transcriptional induction of endothelial nitric oxide synthase type III by lysophosphatidylcholine
49. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C
50. Essential role of phospholipase A2 in endothelial cell-induced modification of low density lipoprotein
51. Possible role of mammalian secretary type II phospholipase A2 in T-lymphocyte activation: Implication in propagation of inflammatory reaction
52. Lysophosphatidylcholine: A chemotactic factor for human monocytes and its potential role in atherosclerosis
53. Functional analysis of the human endothelial nitric oxide synthase promoter
54. Role of Sp1 in transcriptional activation of human nitric oxide synthase-3 gene
55. Transcriptional regulation of endothelial nitric oxide synthase by lysophosphatidylcholine
56. Upregulation of endothelial nitric oxide synthase promoter by the phosphatidylcholine 3-kinase γ/Janus kinase 2/MEK-1-dependent pathway
57. Transcriptional regulation of endothelial nitric oxide synthase by an interaction between casein kinase 2 and protein phosphatase 2A
58. Therapeutic potential of nitric oxide synthase gene manipulation